Live from the NIH registry
Studies recruiting near Eugene right now
Top 25 of 148 recruiting studies, sorted by proximity — each links to its official registry page
OssiMend BA in Posterolateral Instrumented Lumbar Fusion
Spinal Disease, Degenerative Disc Disease
N/A
Observational 120 participants sought
McKenzie-willamette Medical Center — Eugene, Oregon (1.6 mi)
· Sponsor: Collagen Matrix
K-ORCA: Testing a Decision Support Tool and Group Process for Selecting Interventions
Child Abuse, Decision Making
N/A
Interventional 80 participants sought
Chestnut Health Systems — Eugene, Oregon (1.6 mi)
· Sponsor: Chestnut Health Systems
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Oncology Associates of Oregon (Willamette Valley Cancer Institute and Research Center) — Eugene, Oregon (1.6 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Low Grade Serous Ovarian Cancer
Phase 3
Interventional 270 participants sought
Willamette Valley Cancer Institute — Eugene, Oregon (1.6 mi)
· Sponsor: Verastem, Inc.
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Large B-cell Lymphoma
Phase 2
Interventional 250 participants sought
Oncology Associates of Oregon — Eugene, Oregon (1.6 mi)
· Sponsor: Allogene Therapeutics
SBIR/ STTR Family Check-up Online
Mental Health, Parenting Stress
N/A
Interventional 1,270 participants sought
Prevention Science Institute — Eugene, Oregon (1.6 mi)
· Sponsor: University of Oregon
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 270 participants sought
517 — Eugene, Oregon (1.6 mi)
· Sponsor: Corcept Therapeutics
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking
Keratoconus, Unstable, Bacterial Keratitis
Phase 1
Interventional 300 participants sought
Pacific Clear Vision Institute — Eugene, Oregon (1.6 mi)
· Sponsor: Pacific Clear Vision Institute
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Chronic Low-back Pain, Vertebrogenic Pain Syndrome
N/A
Observational 1,500 participants sought
Pacific Sports and Spine — Eugene, Oregon (1.6 mi)
· Sponsor: Boston Scientific Corporation
MYLUNG Consortium Part 3: Observational Study
Carcinoma, Non-Small-Cell Lung
N/A
Observational 7,500 participants sought
Willamette Valley Cancer Institute and Research Center — Eugene, Oregon (1.6 mi)
· Sponsor: US Oncology Research
Essential Amino Acid Supplementation for Femoral Fragility Fractures
Femoral Fracture, Fragility Fracture
Phase 2
Interventional 60 participants sought
Slocum Center for Orthopedics & Sports Medicine — Eugene, Oregon (1.6 mi)
· Sponsor: Michael C Willey
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
Genetic Disease
N/A
Observational 20,000 participants sought
University of Oregon — Eugene, Oregon (1.6 mi)
· Sponsor: National Human Genome Research Institute (NHGRI)
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Willamette Valley Clinical Studies — Eugene, Oregon (1.6 mi)
· Sponsor: Sparrow Pharmaceuticals
Testing Just-in-Time Adaptive Interventions (JITAIs) to Prevent Goal Disengagement in Response to Weight Regain
Overweight or Obesity
N/A
Interventional 120 participants sought
Oregon Research Institute Community and Evaluation Services — Springfield, Oregon (4.8 mi)
· Sponsor: ORI Community and Evaluation Services
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
B-cell Lymphoma, Chronic Lymphocytic Leukemia
Phase 1, Phase 2
Interventional 150 participants sought
Oncology Associates of Oregon — Eugene, Oregon (1.6 mi)
· Sponsor: Nurix Therapeutics, Inc.
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Verum Research, LLC — Eugene, Oregon (1.6 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
HR+/HER2- Breast Cancer
Phase 3
Interventional 1,056 participants sought
Oncology Associates of Oregon Willamette Valley Cancer Center — Eugene, Oregon (1.6 mi)
· Sponsor: BeOne Medicines
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
Benign Prostatic Hyperplasia
N/A
Interventional 92 participants sought
Oregon Urology Institute — Springfield, Oregon (4.8 mi)
· Sponsor: Urotronic Inc.
Garden-fresh Foods and Gut Microbiomes
Gut Microbiome
N/A
Interventional 20 participants sought
Institute for Health in the Built Environment, University of Oregon — Eugene, Oregon (1.6 mi)
· Sponsor: University of Oregon
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Epithelial Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 140 participants sought
Oncology Associates of Oregon, P.C. /ID# 275006 — Eugene, Oregon (1.6 mi)
· Sponsor: AbbVie
Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups and Individualized Services
Language Delay, Substance Use Disorders
N/A
Interventional 244 participants sought
Prevention Science Institute — Eugene, Oregon (1.6 mi)
· Sponsor: University of Oregon
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Oligometastatic Prostate Cancer (OMPC)
Phase 3
Interventional 450 participants sought
Oregon Urology Institute — Springfield, Oregon (4.8 mi)
· Sponsor: Novartis Pharmaceuticals
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Multiple Myeloma
Phase 2
Interventional 100 participants sought
Oncology Associates of Oregon — Eugene, Oregon (1.6 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Melanoma
Phase 3
Interventional 560 participants sought
USOR Willamette Valley Cancer Institute and Research Center — Eugene, Oregon (1.6 mi)
· Sponsor: Regeneron Pharmaceuticals
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase 2
Interventional 400 participants sought
Oregon Urology Institute — Springfield, Oregon (4.8 mi)
· Sponsor: Dendreon